Abstract
The activated androgen receptor (AR) promotes prostate cancer (PCa) growth. AR antagonists repress the AR by recruitment of corepressors. Not much is known about the inactivation of AR by corepressors in the presence of agonists (androgens). Here we show that the corepressor LCoR acts as an androgen-dependent corepressor that represses human PCa growth in vivo. In line with this, progressive decrease of ligand-dependent corepressor expression was observed in the PCa TRAMP mouse model with increasing age. LCoR interacts with AR and is recruited to chromatin in an androgen-induced manner. Unexpectedly, the LXXLL motif of LCoR is dispensable for interaction with the AR. Rather, the data indicate that LCoR interacts with the AR DNA binding domain on DNA. Interestingly, the interaction of LCoR with AR is inhibited by signaling pathways that are associated with androgen-independent PCa. Here we also show that the Src kinase inactivates the corepressive function of LCoR. Interfering with endogenous Src function by a dominant negative Src mutant, the growth inhibitory activity of LCoR is enhanced in vivo in a xenograft mouse model system. Thus, our studies indicate a role of LCoR as an AR corepressor and a tumor suppressor. Further, the decreased expression or inactivation of LCoR is as an important step toward PCa carcinogenesis in vivo.
Highlights
Prostate cancer (PCa) growth is promoted by the androgen receptor (AR)
Coexpression of Src along with LCoR resulted in an increase in colony number as compared with LCoR alone. These results further indicate that LCoR represses PCa cell growth and that its function is largely governed by Src kinase activity in PCa cells
We have characterized LCoR as a novel androgen-dependent AR corepressor that regulates the growth of PCa cells in vitro and in vivo
Summary
Prostate cancer (PCa) growth is promoted by the androgen receptor (AR). Castration-resistant PCa is associated with activated signaling pathways. Results: LCoR represses human PCa growth in vivo. Src kinase inactivates the corepressive function of LCoR in vivo. Conclusion: LCoR, a novel corepressor for AR, inhibits PCa cell growth in vivo. LCoR is inactivated by Src kinase in castrationresistant PCa. Significance: As a ligand-dependent CoR, LCoR is able to inhibit AR activity in the presence of agonists in comparison to SMRT, Alien, or NCoR and could offer new therapies without applying antagonists, which result in androgen-independent growth. The target could be the here-described Src pathway
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.